Trod medical receives a new patent allowance for prostate focal therapy encage device

Trod Medical, the medical device company with FDA-cleared and CE Marked products for focal ablation, announces the issuance of a new patent allowance by the United States Patent and Trademark Office, entitled “Method to remove a tumor using a percutaneous surgical instrument”.

The patent covers a surgical technique used with Trod Medical’s Encage radio frequency ablation device, including the technique of enlarging the margin of the tissue destruction area, particularly important in Prostate Focal Therapy.

Trod Medical’s Encage is a bipolar, radio frequency-based, helical ablation probe enabling minimally invasive focused soft tissue ablation.

Trod Medical
trodmedical.com